All stock lists
Unlock the score
Precision Biosciences Inc (NASDAQ:DTIL)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
6.41-0.23 (-3.46%)
Market cap
$177M
Insider Score
Health Score
Analyst consensus
Listed since
Mar 28, 2019
Website
Insider Score
/ 100
DTIL Insider Score
PRECISION BIOSCIENCES INC has a live Insider Score.
Scored on 3 qualifying trades from 3 insiders in the last 90 days.
DTIL Stock Insider Trading Activity
DTIL stock’s insider trading shows 3 purchases for an estimated $29.50K by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
Scored window · last 90 days3 qualifying buys3 insiders$29.50K bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Frankel Stanley Director | Buy | 1,000 | $6.00 | $6.00K | 2.5% | 41,478 | Sep 28, 2026 | DCluster BuyDilution | Form 4 |
| Brown Melinda Director | Buy | 1,135 | $6.27 | $7.12K | 2.6% | 45,481 | Sep 25, 2026 | DCluster BuyDilution | Form 4 |
| Germano Geno J Director | Buy | 2,609 | $6.28 | $16.38K | 5.8% | 47,492 | Sep 25, 2026 | DCluster BuyDilution | Form 4 |
| Brown Melinda Director | Option exercise | 21,000 | — | — | 90.0% | 44,346 | May 20, 2026 | — | Form 4 |
| Pire Shari Lisa Director | Option exercise | 21,000 | — | — | 150% | 35,028 | May 20, 2026 | — | Form 4 |
| Germano Geno J Director | Option exercise | 21,000 | — | — | 87.9% | 44,883 | May 20, 2026 | — | Form 4 |
| Buehler Kevin Director | Option exercise | 21,000 | — | — | 74.6% | 49,137 | May 20, 2026 | — | Form 4 |
| Frankel Stanley Director | Option exercise | 21,000 | — | — | 108% | 40,478 | May 20, 2026 | — | Form 4 |
| Amoroso Michael CEO | Sell | 20,559 | $3.84 | $78.95K | 7.8% | 243,392 | Feb 18, 2026 | — | Form 4 |
| Scimeca Dario Other | Sell | 4,925 | $3.84 | $18.91K | 8.0% | 56,457 | Feb 18, 2026 | — | Form 4 |
| SMITH J. JEFFERSON Other | Sell | 4,925 | $3.84 | $18.91K | 3.9% | 121,926 | Feb 18, 2026 | — | Form 4 |
| Kelly John Alexander CFO | Sell | 8,149 | $3.84 | $31.29K | 6.1% | 125,883 | Feb 18, 2026 | — | Form 4 |
| SMITH J. JEFFERSON Other | Option exercise | 16,667 | — | — | 15.1% | 126,851 | Feb 17, 2026 | — | Form 4 |
| Scimeca Dario Other | Option exercise | 16,667 | — | — | 37.3% | 61,382 | Feb 17, 2026 | — | Form 4 |
| Kelly John Alexander CFO | Option exercise | 27,584 | — | — | 25.9% | 134,032 | Feb 17, 2026 | — | Form 4 |
| Amoroso Michael CEO | Option exercise | 67,797 | — | — | 34.6% | 263,951 | Feb 17, 2026 | — | Form 4 |
| Amoroso Michael CEO | Sell | 34,799 | $4.17 | $145.11K | 15.1% | 196,154 | Jan 22, 2026 | — | Form 4 |
| SMITH J. JEFFERSON Other | Option exercise | 16,219 | — | — | 15.6% | 120,384 | Jan 21, 2026 | — | Form 4 |
| Scimeca Dario Other | Sell | 8,854 | $4.03 | $35.68K | 16.5% | 44,715 | Jan 21, 2026 | — | Form 4 |
| Kelly John Alexander CFO | Sell | 15,213 | $4.03 | $61.31K | 12.5% | 106,448 | Jan 21, 2026 | — | Form 4 |
| SMITH J. JEFFERSON Other | Sell | 10,200 | $4.03 | $41.11K | 8.5% | 110,184 | Jan 21, 2026 | — | Form 4 |
| Kelly John Alexander CFO | Option exercise | 13,900 | — | — | 17.1% | 95,086 | Jan 20, 2026 | — | Form 4 |
| Amoroso Michael CEO | Option exercise | 8,888 | — | — | 7.7% | 124,463 | Jan 20, 2026 | — | Form 4 |
| Amoroso Michael CEO | Option exercise | 37,069 | — | — | 29.8% | 161,532 | Jan 20, 2026 | — | Form 4 |
| Amoroso Michael CEO | Option exercise | 69,421 | — | — | 43.0% | 230,953 | Jan 20, 2026 | — | Form 4 |
| Scimeca Dario Other | Option exercise | 1,978 | — | — | 7.0% | 30,236 | Jan 20, 2026 | — | Form 4 |
| Scimeca Dario Other | Option exercise | 8,425 | — | — | 27.9% | 38,661 | Jan 20, 2026 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Buy (P) — Open-market or private purchase
- Sell (S) — Open-market or private sale
- Option exercise (M) — Exercise or conversion of an exempt derivative
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.